Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
2.
Eur J Midwifery ; 5: 29, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34316547

RESUMO

INTRODUCTION: The aim of our study is to describe the management of a maternity ward in a referral center during the COVID-19 pandemic and 2020 lockdown. METHODS: This is a retrospective single-center study. We analyzed the records of all women consecutively admitted to our delivery ward during lockdown and compared them with those of women admitted in the same period in 2019. RESULTS: The number of patients (1260) admitted to our department in 2020 was similar (1215) to that in 2019. Among patients admitted during lockdown, 50 presented with a Sars-CoV-2 infection (3.9%). In 2020, the number of antenatal check-ups was lower than in 2019 [7.9 (1.5) vs 8.2 (1.3), p<0.001] and the rate of labor inductions was higher [436 (34.6) vs 378 (31.1), p=0.008] although no difference in delivery mode was found. Moreover, women admitted during lockdown were more likely to give birth alone [140 (11.1) vs 50 (4.1), p<0.001]. However, during 2020, the rate of mother and newborn skinto-skin contact [1036 (82.2) vs 897 (73.8), p<0.001] and that of breastfeeding within 2 hours from birth [1003 (79.6) vs 830 (68.3), p<0.001] was higher. We found no significant differences in maternal or neonatal outcomes. CONCLUSIONS: Despite the COVID-19 pandemic, we were able to guarantee a safe birth assistance to all pregnant women, both for those infected and those not infected by Sars-CoV-2.

3.
Acta Obstet Gynecol Scand ; 99(5): 644-650, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-31898313

RESUMO

INTRODUCTION: The objective of the present study is to compare the sonographic measurement of subcutaneous adipose thickness and visceral adipose thickness during 1st trimester screening for aneuploidies between non-diabetic pregnant women and patients who develop 1st trimester or 2nd trimester gestational diabetes mellitus (GDM). MATERIAL AND METHODS: Adipose thickness was measured by transabdominal ultrasound imaging in pregnant women attending our clinic for screening for fetal aneuploidies between 11 and 13 weeks of gestation. During the 1st trimester all patients were evaluated for fasting glycemia in accordance with the International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommendations. Patients with confirmed fasting glycemia (FPG) ≥92 mg/dL were diagnosed as 1st trimester GDM. Patients with FPG <92 mg/dL underwent a 75-g oral glucose tolerance test between 24 and 28 weeks. RESULTS: The study population included 238 non-diabetic women, 29 women with 1st trimester GDM and 28 women with 2nd trimester GDM. Mean subcutaneous adipose thickness and visceral adipose thickness values in non-diabetic women were 9.8 mm (standard deviation [SD = 4.9) and 7.2 mm (SD = 3.5), respectively. Values in women with 1st trimester GDM were 12.8 mm (SD = 6.5) and 9.9 mm (SD = 4.4). In the 2nd trimester GDM group, the mean subcutaneous adipose thickness was 11.1 mm (SD = 4.6) and the mean visceral adipose thickness 10.5 mm (SD = 5.3). Multiple logistic regression analysis showed that visceral adipose thickness, but not subcutaneous adipose thickness, was significantly and independently associated with both 1st trimester GDM (OR 1.15, 95% CI 1.02-1.29) and 2nd trimester GDM (odds ratio [OR] 1.19, 95% confidence interval [CI] 1.05-1.34). CONCLUSIONS: Sonographic thickness of maternal visceral adipose tissue was greater in women with GDM than in non-diabetic patients, independently of other known risk factors associated with GDM in the 1st and in the 2nd trimester of pregnancy. Thus, this measurement may be considered of clinical use in 1st trimester screening.


Assuntos
Tecido Adiposo/diagnóstico por imagem , Diabetes Gestacional/diagnóstico por imagem , Obesidade/complicações , Dobras Cutâneas , Adulto , Aneuploidia , Feminino , Teste de Tolerância a Glucose , Humanos , Programas de Rastreamento , Gravidez , Primeiro Trimestre da Gravidez , Ultrassonografia , Adulto Jovem
4.
Hum Reprod ; 26(7): 1659-64, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21489976

RESUMO

BACKGROUND: Pregnancies conceived by IVF are at increased risk of pre-eclampsia (PE). This study examines the potential mechanism for such association by examining the effect of method of conception on placentation as assessed by uterine artery Doppler at 11-13 weeks' gestation. METHODS: This prospective screening study at 11(+0)-13(+6) weeks for PE in singleton pregnancies used a combination of maternal history and uterine artery pulsatility index (PI). Regression analysis was performed to examine the association between the method of conception and both uterine artery PI and development of PE, after adjustment for maternal characteristics and obstetric history. RESULTS: In the study population of 27 461 pregnancies, conception was spontaneous in 26 538 (96.6%), by IVF in 426 (1.6%) and by use of ovulation induction (OI) drugs in 497 (1.8%) pregnancies. Conception by IVF was associated with an increase in risk for early-PE, requiring delivery before 34 weeks [odds ratio 3.94, 95% confidence interval (CI) 1.51-10.27] but not for late-PE. In the OI group, the risk of early- and late-PE was not increased. In addition to IVF, other significant contributors to the prediction of early-PE were maternal weight, height, African and South Asian racial origin, previous and family history of PE and history of chronic hypertension. Significant contributions in explaining log(10) uterine artery PI were provided from maternal characteristics but not from the method of conception. The median uterine artery PI multiple of the median (MoM) in the IVF group (1.02 MoM) and in the OI group (1.03 MoM) were not significantly different from that of the spontaneous conception group (1.01 MoM; P= 0.870 and P= 0.296, respectively). CONCLUSIONS: Conception by IVF substantially increases the risk for early-PE, through a mechanism unrelated to clinically measurable impairment in placental perfusion.


Assuntos
Pré-Eclâmpsia/diagnóstico por imagem , Primeiro Trimestre da Gravidez , Artéria Uterina/diagnóstico por imagem , Útero/irrigação sanguínea , Feminino , Humanos , Incidência , Placenta , Placentação , Pré-Eclâmpsia/epidemiologia , Pré-Eclâmpsia/fisiopatologia , Gravidez , Fluxo Pulsátil , Análise de Regressão , Técnicas de Reprodução Assistida , Ultrassonografia Doppler , Útero/diagnóstico por imagem
5.
Fetal Diagn Ther ; 30(1): 9-22, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21346323

RESUMO

OBJECTIVE: To examine the effect of method of conception on adverse pregnancy outcome after the 11-13 weeks scan. METHODS: Prospective screening study for adverse obstetric outcomes in women with singleton pregnancies and live fetus with no obvious defects at 11(+0)-13(+6) weeks. The method of conception was recorded as spontaneous, in vitro fertilization (IVF) and assisted by ovulation induction (OI) drugs without IVF. Regression analysis was performed to examine the association between the method of conception and pregnancy outcome after adjustment for maternal characteristics. RESULTS: In the study population of 41,577 pregnancies, conception was spontaneous in 40,261 (96.9%), by IVF in 634 (1.5%) and by OI in 682 (1.6%). In the pregnancies conceived by assisted reproductive technology, compared to spontaneous conceptions, there was a higher risk of stillbirth, pre-eclampsia, gestational hypertension, gestational diabetes mellitus, delivery of small for gestational age neonates and caesarean section. However, multiple regression analysis showed that after taking into account maternal characteristics, the only significant contributions of IVF were for pre-eclampsia and elective caesarean section and the contributions of OI were for miscarriage, spontaneous early preterm delivery and small for gestational age. CONCLUSIONS: Conception by IVF and OI is associated with increased risk for adverse pregnancy outcome.


Assuntos
Fertilização in vitro/efeitos adversos , Fertilização , Indução da Ovulação/efeitos adversos , Complicações na Gravidez/epidemiologia , Inglaterra/epidemiologia , Feminino , Humanos , Gravidez , Complicações na Gravidez/etiologia , Resultado da Gravidez , Estudos Prospectivos
6.
Eur J Obstet Gynecol Reprod Biol ; 144(1): 44-7, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19297072

RESUMO

OBJECTIVE: To evaluate if pre-operative GnRH-a modify uterine leiomyoma pseudocapsule and the possible clinical effects of these changes. STUDY DESIGN: The study was performed at the University Federico II of Naples on 33 premenopausal patients submitted to laparotomic myomectomy after treatment with triptorelin depot. 29 untreated patients formed the control group. The operating time, the intraoperative bleeding and the prompt identification of the cleavage plan between myoma and myometrium were evaluated. The pseudocapsule features and the immunoexpression of PCNA and CD34 in this area were studied. RESULTS: Treated patients showed lower blood loss and not clearly identifiable cleavage plan, but without any significant increase in the operating time. Treated lesions showed less evident border between myoma and myometrium and lower PCNA and CD34 pseudocapsule immunoexpression than untreated ones. CONCLUSION: We propose the changes of leiomyoma pseudocapsule as partial explanations of the reported clinical and surgical findings after pre-operative GnRH-a.


Assuntos
Antineoplásicos Hormonais/uso terapêutico , Hormônio Liberador de Gonadotropina/agonistas , Leiomioma/tratamento farmacológico , Leiomioma/cirurgia , Cuidados Pré-Operatórios/métodos , Pamoato de Triptorrelina/uso terapêutico , Neoplasias Uterinas/tratamento farmacológico , Neoplasias Uterinas/cirurgia , Adulto , Antígenos CD34/metabolismo , Antineoplásicos Hormonais/farmacologia , Perda Sanguínea Cirúrgica/prevenção & controle , Proliferação de Células/efeitos dos fármacos , Preparações de Ação Retardada , Feminino , Humanos , Leiomioma/irrigação sanguínea , Miométrio/metabolismo , Miométrio/patologia , Miométrio/cirurgia , Neovascularização Patológica/tratamento farmacológico , Antígeno Nuclear de Célula em Proliferação/metabolismo , Pamoato de Triptorrelina/farmacologia , Neoplasias Uterinas/irrigação sanguínea
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...